European Stroke Journal (ESJ) is the official publication of the European Stroke Organisation (ESO). ESJ is a fully peer-reviewed journal, launched in 2016 covering clinical stroke research from all fields. Published research includes, but is not limited to, clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact.
This journal is a member of the Committee on Publication Ethics (COPE).
Launched in 2016 the European Stroke Journal (ESJ) is the official journal of the European Stroke Organisation (ESO), a professional non-profit organization with over 1,400 individual members, and affiliations to numerous related national and international societies.
ESJ covers clinical stroke research from all fields, including clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact. It is open to authors from all relevant medical and health professions. Article types include review articles, original research, protocols, guidelines, editorials and letters to the Editor.
Through ESJ, authors and researchers have gained a new platform for the rapid and professional publication of peer reviewed scientific material of the highest standards; publication in ESJ is highly competitive. The journal and its editorial team has developed excellent cooperation with sister organisations such as the World Stroke Organisation and the International Journal of Stroke, and the American Heart Organization/American Stroke Association and the journal Stroke.
ESJ is fully peer-reviewed and is a member of the Committee on Publication Ethics (COPE). Issues are published 4 times a year (March, June, September and December) and articles are published OnlineFirst prior to issue publication.
|Professor Foad Abd-Allah MD||Cairo University, Egypt|
|Dr Rufus Akinyemi MBBS, MSc, PhD, MWACP, FMCP||University of Ibadan, Nigeria|
|Professor Ale Algra MD||University Medical Center Utrecht, Netherlands|
|Professor Grethe Andersen MD, DMSc||Aarhus University Hospital, Denmark|
|Professor Philip Bath BSc MB BS MD FRCPath FRCP FESO FAHA FBHS FBPhS DSc FMedSci||University of Nottingham, UK|
|Professor Oscar R. Benavente MD, FRCPC||University of British Columbia, Canada|
|Professor Eivind Berge PhD||Oslo University Hospital, Norway|
|Professor Michael Brainin MD, PhD, Dr (hons), FESO FAHA||Danube-University Krems, Austria|
|Professor Martin Brown MA, MD, FRCP||University College London, UK|
|Professor Valeria Caso, MD, PhD, FESO||University of Perugia, Italy|
|Professor Ángel Chamorro MD PhD||University of Barcelona, Spain|
|Professor Christopher Chen BMBCh (Oxon), MRCP (UK), FRCP (Edin)||National University of Singapore, Singapore|
|Professor Hanne Krarup Christensen MD, PhD, DMSci, FESO||Bispebjerg Hospital, Denmark|
|Professor Charlotte Cordonnier MD, PhD||University of Lille, France|
|Professor László Csiba PhD, D.Sci.HAS||Debrecen University, Hungary|
|Professor Antoni Dávalos MD, PhD||Autonomous University of Barcelona, Spain|
|Professor Stephen Davis AM MD FRCP Edin FRACP FAHMS||University of Melbourne, Australia|
|Professor Jacques De Keyser MD,PhD||Universitair Ziekenhuis Brussel, Belgium|
|Professor Vida Demarin MD, PhD||International Institute for Brain Health, Croatia|
|Professor Martin Dichgans MD||University of Munich, Germany|
|Professor Exuperio Díez Tejedor MD, PhD||Autónoma University of Madrid, Spain|
|Professor Matthias Endres MD||Charite – Universitaetsmedizin Berlin, Germany|
|Professor Franz Fazekas MD||Universitätsklinik für Neurologie, Austria|
|Professor José M. Ferro MD, PhD||University of Lisbon, Portugal|
|Professor Urs Fischer MD MSc||University of Bern, Switzerland|
|Professor Zuzana Gdovinová PhD||PP.J. Šafárik University Košice, Slovakia|
|Professor Alla Guekht MD PhD||Moscow Research and Clinical Center for Neuropsychiatry & Russian National Research Medical University, Russia|
|Professor Werner Hacke MD PhD DSc (hon mult)||University of Heidelberg, Germany|
|Professor Robert Hart MD||Population Health Research Institute & McMaster University , Canada|
|Professor Peter Heuschmann MD, MPH||Julius Maximilian University of Würzburg, Germany|
|Professor Jaap Kappelle MD||University Medical Center Utrecht, Netherlands|
|Professor Peter Kelly MD MS FRCPI FESO||Mater University Hospital & University College Dublin, Ireland|
|Professor Dheeraj Khurana MD, DM||Postgraduate Institute of Medical Education and Research, India|
|Professor Jong S. kim MD, PhD||University of Ulsan, Korea|
|Professor C.J.M. Klijn MD, PhD||Radboudumc, Netherlands|
|Professor Yoshihiro Kokubo MD, PhD, FACC, FAHA, FESC, FESO, FJSH||National Cerebral and Cardiovascular Center, Japan|
|Dr Janika Kõrv MD, PhD, FESO||University of Tartu, Estonia|
|Kursad Kutluk MD||University of Dokuz Eylul, Turkey|
|Professor Peter Langhorne PhD||Universty of Glasgow, UK|
|Professor Maarten G. Lansberg MD, PhD||Stanford Stroke Center, USA|
|Professor Kennedy R. Lees MBChB, Bsc (Hons), MD*, FRCP, FRSE, FESO||University of Glasgow, UK|
|Professor Arne Lindgren MD, PhD||Lunds Universitet, Sweden|
|Professor Perttu J. Lindsberg MD PhD||Helsinki University Hospital, Finland|
|Professor Liping Liu MD PhD||Beijing Tiantan Hospital, Capital Medical University, China|
|Professor Ming Liu MD, PhD||Sichuan University, China|
|Professor Sheila Martins MD PhD||Hospital de Clinicas de Porto Alegre, Brazil|
|Professor Jean-Louis Mas MD, PhD||Paris Descartes University, France|
|Dr Ayrton Massaro MD, PhD||Hospital Sirio Libanes São Paulo, Brazil|
|Professor Heinrich Mattle MD||University of Bern, Switzerland|
|Dr Dominick J. H. McCabe PhD, FRCPI, FESO||The Adelaide and Meath Hospital, Ireland|
|Professor Atte Meretoja MD, PhD, MSc, FRACP||Helsinki University Hospital, Finland|
|Dr Patrik Michel MD, FESO, FAHA||Lausanne University Hospital, Switzerland|
|Professor Robert Mikulik MD, PhD||St. Anne's University Hospital, Czech Republic|
|Professor Carlos Molina MD, PhD||Hospital Universitari Vall d´Hebron, Spain|
|Dr Joan Montaner MD PhD||Virgen del Rocio Hospital, Spain|
|Professor Thierry Moulin PhD||University of Franche-Comte, France|
|Professor Maciej Niewada MD PhD||Medical University of Warsaw, Poland|
|Assistant Professor George Ntaios MD, MSc, PhD||University of Thessaly Larissa, Greece|
|Dr Yasushi Okada MD, PhD||National Hospital Organization Kyushu Medical Center, Japan|
|Professor Jeyaraj Pandian MD DM FRACP FRCP FESO||Christian Medical College, India|
|Professor Leonardo Pantoni MD PhD||University of Milan, Italy|
|Professor Alessandro Pezzini MD||Università degli Studi di Brescia, Italy|
|Professor Jukka Putaala MD, PhD, MSc(Stroke)||Helsinki University Hospital, Finland|
|Peter Ringleb MD PhD||University Hospital Heidelberg, Germany|
|Professor Jonathan Rosand MD, MSc||Massachusetts General Hospital, USA|
|Professor Peter Rothwell FMedSci||University of Oxford, UK|
|Professor Simona Sacco MD||University of L’Aquila, Italy|
|Emeritus Professor Peter Sandercock DM||University of Edinburgh, UK|
|Dr Else Sandset PhD||Oslo University Hosptial, Norway|
|Professor Christian Stapf MD||Université de Montréal, Canada|
|Professor Thorsten Steiner MME||Heidelberg University Hospital, Germany|
|Professor Daniel Strbian MD, PhD, MSc (Stroke Med),FESO||Helsinki University Central Hospital, Finland|
|Professor Katharina Sunnerhagen MD, PhD||University of Gothenburg, Sweden|
|Professor Turgut Tatlisumak MD, PhD||Sahlgrenska Academy at University of Gothenburg & Sahlgrenska University Hospital, Sweden|
|Professor Vincent Thijs MD PhD||Austin Health & University of Melbourne, Australia|
|Professor Danilo Toni MD, PhD, FESO||University of Rome, Italy|
|Professor Alexander Tsiskaridze MD PhD DSc||Tbilisi State University, Georgia|
|Professor Georgios Tsivgoulis MD, PhD, MSc, FESO||National & Kapodistrian University of Athens, Greece|
|Dr H. Bart van der Worp MD, PhD||University Medical Center Utrecht, Netherlands|
|Dr Mervyn Vergouwen MD PhD||University Medical Center Utrecht, Netherlands|
|Professor Nils Wahlgren MD, PhD||Karolinska University Hospital, Sweden|
|Professor Joanna Wardlaw MB ChB, MD, FRCR, FRCP, FMedSci, FRSE||University of Edinburgh, UK|
|Professor David Werring FRCP PhD FESO||University College London, UK|
|Professor Lawrence Wong MB MD||Chinese University of Hong Kong, China|
European Stroke Journal is the fully peer-reviewed official journal of the European Stroke Organisation (ESO), a professional non-profit organization with individual members, and affiliations to numerous related national and international societies.
European Stroke Journal covers clinical stroke research from all fields, including clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact. It is open to authors from all relevant medical and health professions. Article types include review articles, original research, protocols, guidelines, editorials and letters to the Editor.
European Stroke Journal has full editorial independence from the European Stroke Organisation.
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/esj to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of European Stroke Journal will be reviewed.
There are no fees payable to submit or publish in this journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
- What do we publish?
1.1 Aims & Scope
1.2 Article types
1.3 Writing your paper
- Editorial policies
2.1 Peer review policy
2.2 Declaration Guidelines for Authors
2.6 Declaration of conflicting interests
2.7 Research ethics and patient consent
2.8 Clinical trials
2.9 Reporting guidelines
- Publishing policies
3.1 Publication ethics
3.2 Contributor's publishing agreement
3.3 Open access and author archiving
- Preparing your manuscript
4.2 Artwork, figures and other graphics
4.3 Supplementary material
4.4 Reference style
4.5 English language editing services
- Submitting your manuscript
5.2 Information required for completing your submission
- On acceptance and publication
6.1 SAGE Production
6.2 Online First publication
6.3 Access to your published article
6.4 Promoting your article
- Further information
Before submitting your manuscript to European Stroke Journal, please ensure you have read the Aims & Scope.
Letter to the Editor
Original research articles, including: randomised controlled trials, other clinical trials, systematic reviews, and meta-analyses
Protocols of randomised controlled trials and other clinical trials
Overviews of a major topics
*Includes references, disclosures, tables and legends
Letters to the Editor Comments arising from recent articles published in the journal are welcomed. Letters are not divided into sections. Letters to the Editor should not include tables, figures or data supplements.
Original Research Articles should include title page, keywords, structured abstract*, introduction, patients and methods, results, discussion (including limitations as appropriate), conclusion, acknowledgements, declarations, references, and up to 6 tables or figures.
*Structured abstracts should include the following headings: Introduction, Patients and methods, Results, Discussion and Conclusion.
Protocols: Protocols should describe scheduled or ongoing studies, and up to 6 tables or figures.
Review Articles should include title page, keywords, structured abstract*, introduction, method, findings, discussion, conclusion, acknowledgements, disclosures, references, and up to 6 tables or figures.
*Structured abstracts should include the following headings:
Purpose, method, findings, discussion and conclusion.
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
1.3.1 Make your article discoverable
When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.
After initial review by the Editor, a decision is made whether to send the manuscript for external peer review. The Editor will select at least two referees and make a recommendation regarding publication based on their feedback. European Stroke Journal adheres to a single-blind peer review process in which the reviewer’s name is routinely withheld from the author unless the reviewer requests a preference for his/her identity to be revealed. The journal aims to have all manuscripts reviewed as rapidly as possible.
The Editor-in-Chief makes the final decision on all manuscripts. The Vice Editor or a Guest Editor may serve as handling editor for manuscripts for which the Editor-in-Chief has a conflict of interests.
As part of the submission process you will be asked to provide the names of peers who should not be called upon to review your manuscript.
European Stroke Journal is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for European Stroke Journal can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.
Please see: ESJ Declaration Policy Document
The following statements should be uploaded under the file type ‘Declarations’ for every manuscript submitted. These will be published at the end of every paper accepted for publication.
Please read the Declaration guidelines for authors (available here carefully before submitting your Declarations document.
1. Conflicting interests (section 2.6)
2. Funding (section 2.5)
3. Informed consent (section 2.7)
4. Ethical approval (section 2.7)
5. Guarantor (section 2.10)
6. Contributorship (section 2.11)
7. Acknowledgements (section 2.4)
Please see the below example of a completed declarations section:
Conflicting interests: MS is an employee of XXX. BF has received grants from XXX.
Funding: This work was supported by the Medical Research Council [grant number XXX]
Informed consent: Written informed consent was obtained from the patient(s) for their anonymized information to be published in this article.
Ethical approval: The ethics committee of XXXX approved this study (REC number: XXXX)
Contributorship: BF and NP researched literature and conceived the study. MS was involved in protocol development, gaining ethical approval, patient recruitment and data analysis. BF wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript
Acknowledgements: We would like to thank XXX XXXX for his assistance and guidance in this research.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published,
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section within your declarations document (see section 2.2). Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
2.4.1 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
European Stroke Journal requires all authors to acknowledge their funding in a consistent fashion under a separate heading within their declarations document (see section 2.2). Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of European Stroke Journal to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included within your declarations document (see section 2.2). If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section and within your declarations document whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants.
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
European Stroke Journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
The Guarantor is the person willing to take full responsibility for the article, including for the accuracy and appropriateness of the reference list. This will often be the most senior member of the research group and is commonly also the author for correspondence. Please state this person’s name as initials within your declarations document (see section 2.2).
For multi-authored papers this statement should outline what each party contributed to the authorship of the paper. Authors should be identified by their initials. An example is shown below.
BF and NP researched literature and conceived the study. MS was involved in protocol development, gaining ethical approval, patient recruitment and data analysis. BF wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway
European Stroke Journal and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway.
European Stroke Journal offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines. Please note, figure files should not be submitted in PDF format.
Figures supplied in colour will appear in colour online and in the print issue. There is no charge for reproducing figures in colour in the printed version.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files.
European Stroke Journal adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
European Stroke Journal is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/esj to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognised.
We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their ORCIDs as part of the submission process. If you don’t already have one you can create one here.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
5.2.1 Title Page
The first page of your manuscript should be the Title Page and should include the following information:
- All author names and affiliations
- Corresponding author contact details
- Structured abstract
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that all declarations are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.
SAGE provides authors with online access to their final article.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximise your article’s impact with Kudos.
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the European Stroke Journal editorial office as follows: